143 related articles for article (PubMed ID: 7355241)
1. Current cancer immunology.
Prog Exp Tumor Res; 1980; 25():1-295. PubMed ID: 7355241
[No Abstract] [Full Text] [Related]
2. [Immunotherapy of cancer. Experiments in the modification of tumor antigenicity].
Mizukami T; Takamura Y
Arch Geschwulstforsch; 1971; 37(1):33-44. PubMed ID: 4102699
[No Abstract] [Full Text] [Related]
3. The immunology of cancer.
Angel Basombrío M
J Oral Pathol; 1973; 2(5):231-53. PubMed ID: 4207800
[No Abstract] [Full Text] [Related]
4. Immunotherapy of cancer.
Oettgen HF
N Engl J Med; 1977 Sep; 297(9):484-91. PubMed ID: 301988
[No Abstract] [Full Text] [Related]
5. Immunotherapy of malignant disease (Part 2).
MacGregor AB; Falk RE
J R Coll Surg Edinb; 1976 Jan; 21(1):43-9. PubMed ID: 765453
[No Abstract] [Full Text] [Related]
6. Introduction: diagnosis and immunotherapy of cancer.
Klein E
Natl Cancer Inst Monogr; 1972 Dec; 35():331-9. PubMed ID: 4349151
[No Abstract] [Full Text] [Related]
7. Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity.
Mihich E
Natl Cancer Inst Monogr; 1971 Dec; 34():90-102. PubMed ID: 4400958
[No Abstract] [Full Text] [Related]
8. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
Schlom J; Weeks MO
Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
[No Abstract] [Full Text] [Related]
9. Immunological response in patients receiving Corynebacterium parvum therapy.
Osborn DE; Castro JE
Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
[No Abstract] [Full Text] [Related]
10. Ex vivo activated monocytes and adoptive immunotherapy trials in colon cancer patients.
Stevenson HC; Foon KA; Sugarbaker PH
Prog Clin Biol Res; 1986; 211():75-82. PubMed ID: 3515364
[No Abstract] [Full Text] [Related]
11. [Tumor immunology].
Milas L; Silobrcić V
Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
[No Abstract] [Full Text] [Related]
12. A guinea pig model for tumor immunology. A summary.
Rapp HJ
Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
[No Abstract] [Full Text] [Related]
13. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.
Rosenberg SA; Lotze MT; Muul LM; Leitman S; Chang AE; Ettinghausen SE; Matory YL; Skibber JM; Shiloni E; Vetto JT
N Engl J Med; 1985 Dec; 313(23):1485-92. PubMed ID: 3903508
[TBL] [Abstract][Full Text] [Related]
14. Active immunotherapy against cancer: present status.
Morton DL
Semin Oncol; 1986 Jun; 13(2):180-5. PubMed ID: 3520826
[No Abstract] [Full Text] [Related]
15. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
16. The Twin Tiers Community Clinical Oncology Program (TTCCOP) experience: the first year.
Enck RE; Boselli B; Rosencrans H; Maiden C; Rogers B
Prog Clin Biol Res; 1986; 216():417-22. PubMed ID: 3523535
[No Abstract] [Full Text] [Related]
17. The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy.
Domenick NP
Nurs Clin North Am; 1978 Jun; 13(2):369-80. PubMed ID: 353752
[No Abstract] [Full Text] [Related]
18. Immunotherapy in colorectal cancer.
Wallack MK
Mo Med; 1981 Jan; 78(1):23-5. PubMed ID: 7219405
[No Abstract] [Full Text] [Related]
19. The role of immunology in the diagnosis and treatment of cancer.
Humphrey LJ; Pierce GE
Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
[No Abstract] [Full Text] [Related]
20. [5 years' experience in the immunotherapy of human cancer].
Humphrey LJ; Boehm OR; Boehm BJ; Jewell WR
Zentralbl Chir; 1973 Sep; 98(35):1241-6. PubMed ID: 4784998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
